Teva Pharmaceutical Industries Limited
TEVJFOTCHealthcare● Active
$30.34
+$0.15(+0.50%)
Market Cap$35.3B
P/E Ratio—
52W High$32.84
52W Low$14
Teva Pharmaceutical Industries Limited (TEVJF) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · TEVJF · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $18.68B | $16.54B | $15.85B | $14.93B | $15.88B |
| Cost of Revenue | $9.05B | $8.48B | $8.20B | $7.95B | $8.28B |
| Gross Profit | $9.75B | $8.06B | $7.65B | $6.97B | $7.59B |
| Gross Margin %(computed) | 52.17% | 48.74% | 48.25% | 46.72% | 47.83% |
| Operating Expenses | |||||
| R&D Expenses | $1.01B | $1.00B | $1.04B | $0.84B | $0.97B |
| G&A Expenses | $1.29B | $1.16B | $1.16B | $1.18B | $1.10B |
| Total Operating Expenses | $4.99B | $8.37B | $7.21B | $9.17B | $5.88B |
| Operating Income | $2.16B | ($0.30B) | $0.43B | $2.56B | $1.72B |
| Operating Margin %(computed) | 11.55% | -1.83% | 2.73% | 17.14% | 10.81% |
| Interest Income | $0.00B | $0.00B | ($0.04B) | $0.92B | $0.00B |
| Interest Expense | $1.01B | $0.96B | $1.06B | $0.97B | $1.05B |
| Income Before Tax | $1.34B | ($1.28B) | ($0.62B) | ($3.00B) | $0.67B |
| Income Tax Expense | ($0.19B) | $0.68B | ($0.01B) | ($0.64B) | $0.21B |
| Net Income | $1.53B | ($1.64B) | ($0.56B) | ($2.45B) | $0.42B |
| Net Margin %(computed) | 8.18% | -9.91% | -3.53% | -16.39% | 2.63% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $1.33 | $-1.45 | $-0.50 | $-2.19 | $0.38 |
| Wtd Avg Shares | 1.15B | 1.13B | 1.12B | 1.11B | 1.10B |
| EBITDA | $5.43B | $0.78B | $4.33B | ($0.83B) | $3.11B |
| EBITDA Margin %(computed) | 29.08% | 4.70% | 27.34% | -5.59% | 19.60% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Teva Pharmaceutical Industries Limited data
About Teva Pharmaceutical Industries Limited (TEVJF) Income Statement
Teva Pharmaceutical Industries Limited (TEVJF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, TEVJF reported revenue of $18.68B, gross profit of $9.75B (gross margin 52.17%), and net income of $1.53B — a net profit margin of 8.18%.
Frequently asked questions
TEVJF · 4 questionsTeva Pharmaceutical Industries Limited (TEVJF) reported revenue of $18.68B for 2025, up 12.9% year-over-year.
TEVJF revenueTEVJF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08